Latest: OEM instruments for secure sample tracking
Latest: Expanding the immunohistochemistry (IHC) workflow with patient-free positive controls
Latest: Harnessing cutting-edge proteogenomics in the quest for novel drug targets
Latest: What the UK’s FSA wants to see on submissions for CBD product authorization
Latest: Promoting more sustainable mining practices with Malvern Panalytical’s water monitoring...
Latest: 10 expert webinars coming up this week
Latest: Biochemical methane potential: Anaerobic digestion for a renewable and programmable...
Vote for the Best New Clinical Products in the 2021 Scientists’ Choice Awards
World-leading speakers announced for the SelectScience Virtual Clinical Science Summit 2021
Automated incubators and storage systems increase throughput and sample protection
NanoVibronix has announced the start of a real-world patient study of UroShield
The Orchestrated Lab webinar series: Explore the latest in LIMS, artificial intelligence, cloud...
10 expert webinars coming up this week
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
The essential guide to ELISA automation
Ensuring detection of novel antimicrobial resistant strains
Novum Simplified Liquid Extraction (SLE) Application Guide
The tasty tech that ensures QC in beer brewing
Introducing the Novum PRO
DNA/RNA Purification and Analysis
Pre-Clinical and Clinical Automation
Cell Counting Technology
Cell Analysis Microscopy Equipment
Virtual Cancer & Immunology Research Summit
21 May 21 - 25 May 21
07 Jun 21 - 11 Jun 21
22 Jun 21 - 23 Jun 21
SLAS Europe 2021
22 Jun 21 - 25 Jun 21
12 Jul 21 - 16 Jul 21
LGC has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 200 scientists across three UK facilities. Read more...
As regulatory pressure increases on pharmaceutical companies to investigate the potential interaction between a dosage form and the components of the primary closure and transfer system employed, leachables and extractables studies are be... Read more...
LGC is highly experienced in the application of a broad range of material characterisation techniques and packages and has the knowledge to support your product development from discovery to product registration and beyond. Read more...
Within the pharmaceutical sector, there is an increasing regulatory requirement for the characterisation and counting of visible and sub-visible foreign particles in pharmaceutical products from a safety, quality and efficacy perspective. Read more...
Bringing together Axolabs, Biosearch Technologies and the broader analytical and bioanalytical capabilities available across the company, LGC has a unique heritage and expertise in the development oligonucleotide therapeutics and nucleic ... Read more...
The Meridian™ dispenser is a high speed non-contact liquid dispensing instrument that can be configured with either a single, or 8-channel dispensing head, and can dispense 1 µL of PCR master mix into a 1536-well p... Read more...